Home > Financial Ratios > HIKAL

HIKAL
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for HIKAL
Please provide your vote to see the results

HIKAL Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 23.712.67-24.025.3618.42

What is the latest Core EBITDA Growth ratio of HIKAL ?

The latest Core EBITDA Growth ratio of HIKAL is 23.71 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202523.71
Mar20242.67
Mar2023-24.02
Mar20225.36
Mar202118.42

How is Core EBITDA Growth of HIKAL Trending?

Years Core EBITDA Growth % Change
Mar2025 23.71
788.01
Mar2024 2.67
Positive
Mar2023 -24.02
Negative
Mar2022 5.36
-70.90
Mar2021 18.42 -

Other Financial Ratios of HIKAL


Compare Core EBITDA Growth ratio of peers of HIKAL

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
HIKAL ₹2,773.0 Cr -7.5% 3.9% -9.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹441,958.0 Cr -3% -5.2% 17.9% Stock Analytics
DIVIS LABORATORIES ₹247,576.0 Cr 0.2% 9.7% 56.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,233.0 Cr 1.3% 2% 36.5% Stock Analytics
CIPLA ₹110,273.0 Cr -2.2% -6.6% -10.5% Stock Analytics
DR REDDYS LABORATORIES ₹96,906.4 Cr 1.4% -3.7% -8.8% Stock Analytics


HIKAL Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
HIKAL

-7.5%

3.9%

-9.6%

SENSEX

-2.3%

-4.1%

-7.4%


You may also like the below Video Courses